Timolol Maleate Solution
Product Images NDC 82260-818

8 FDA label images from Bausch & Lomb Americas Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Timolol Maleate (NDC 82260-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Americas Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem (Image 01)

Chem (Image 01)
Chemical structure diagram of Timolol Maleate, showing the molecular arrangement of its chemical components, including heterocyclic groups and carboxylic acid groups.*
FDA Label Image

.5 Carton (Image 02)

.5 Carton (Image 02)
Packaging label for Timolol Maleate Ophthalmic Gel Forming Solution 0.5% by Bausch & Lomb. The sterile eye drop solution comes in a 5 mL package. The label includes storage instructions to keep between 15° to 25°C and avoid freezing, dosage instructions of 1 drop daily, active ingredient content equivalent to 5 mg/mL timolol, and distributor and manufacturer information for Bausch & Lomb Americas Inc.*
FDA Label Image

Graphs (Image 04)

Graphs (Image 04)
Figure 1 presents two line graphs showing mean intraocular pressure (IOP) with standard deviation (mm Hg) over 24 weeks from a U.S. study. The top graph displays IOP at trough (Hour 0) and the bottom graph at peak (Hour 2) comparing Timolol Maleate Ophthalmic Gel Forming Solution 0.5% dosed once daily (q.d.) and Timolol Maleate Ophthalmic Solution 0.5% dosed twice daily (b.i.d.). Both treatments show similar IOP trends over time.*
FDA Label Image

Graph2 (Image 05)

Graph2 (Image 05)
Two line graphs comparing Timolol Maleate Ophthalmic Gel Forming Solution 0.5% (q.d., N=226) and Timolol Maleate Ophthalmic Solution 0.5% (b.i.d., N=116). The top graph shows intraocular pressure (mm Hg) at trough (Hour 0) over 24 weeks. The bottom graph shows intraocular pressure at peak (Hour 2) over 24 weeks. Both graphs have time in weeks on the x-axis and mm Hg on the y-axis, with error bars indicating variability.*
FDA Label Image

Timoptic-xe_ifu_fig A (Image 06)

Timoptic-xe_ifu_fig A (Image 06)
Illustration showing a close-up of two hands demonstrating how to twist the cap off an ophthalmic solution bottle. Circular arrows indicate the twisting motion for opening the bottle.*
FDA Label Image

Timoptic-xe_ifu_fig B (Image 07)

Timoptic-xe_ifu_fig B (Image 07)
An instructional line drawing showing a hand administering eye drops into an eye, demonstrating proper technique for ophthalmic solution application.*
FDA Label Image

Timoptic-xe_ifu_fig C (Image 08)

Timoptic-xe_ifu_fig C (Image 08)
An instructional line drawing showing the proper technique for administering ophthalmic solution drops into the eye. The illustration depicts a hand holding a dropper bottle aimed at an open eye, with a droplet about to fall into the eye while the other hand gently pulls down the lower eyelid.*
FDA Label Image

.25 Carton (Image 09)

.25 Carton (Image 09)
Box label for Timolol Maleate Ophthalmic Gel Forming Solution 0.5%, an eye drop solution by Bausch & Lomb Americas Inc. The sterile product contains timolol maleate equivalent to 5 mg/mL timolol in a 5 mL package. Storage instructions and dosage directions are included, along with manufacturer and distributor details from Bausch & Lomb.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.